Zacks Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.5M | Sell |
84,157
-1,466
| -2% | -$397K | 0.18% | 122 |
|
|
2025
Q4 | $21.5M | Buy |
85,623
+1,936
| +2% | +$514K | 0.17% | 132 |
|
|
2025
Q3 | $24M | Buy |
83,687
+2,318
| +3% | +$621K | 0.19% | 124 |
|
|
2025
Q2 | $21.4M | Buy |
81,369
+323
| +0.4% | +$78.7K | 0.18% | 129 |
|
|
2025
Q1 | $18.9M | Buy |
81,046
+2,804
| +4% | +$680K | 0.18% | 135 |
|
|
2024
Q4 | $17.9M | Sell |
78,242
-9,461
| -11% | -$2.17M | 0.17% | 137 |
|
|
2024
Q3 | $19.6M | Buy |
87,703
+10,125
| +13% | +$2.23M | 0.17% | 134 |
|
|
2024
Q2 | $15.8M | Buy |
77,578
+6,361
| +9% | +$1.29M | 0.18% | 127 |
|
|
2024
Q1 | $15.6M | Buy |
71,217
+5,577
| +8% | +$1.23M | 0.17% | 134 |
|
|
2023
Q4 | $14.9M | Buy |
65,640
+845
| +1% | +$178K | 0.18% | 120 |
|
|
2023
Q3 | $13M | Sell |
64,795
-30,514
| -32% | -$6.44M | 0.17% | 129 |
|
|
2023
Q2 | $19.8M | Buy |
95,309
+2,127
| +2% | +$413K | 0.25% | 98 |
|
|
2023
Q1 | $18.4M | Buy |
93,182
+4,403
| +5% | +$906K | 0.25% | 104 |
|
|
2022
Q4 | $18M | Buy |
88,779
+722
| +0.8% | +$141K | 0.25% | 92 |
|
|
2022
Q3 | $15.5M | Sell |
88,057
-1,737
| -2% | -$356K | 0.25% | 96 |
|
|
2022
Q2 | $18.1M | Buy |
89,794
+2,636
| +3% | +$562K | 0.28% | 90 |
|
|
2022
Q1 | $19.7M | Sell |
87,158
-1,616
| -2% | -$380K | 0.27% | 92 |
|
|
2021
Q4 | $24M | Sell |
88,774
-12,195
| -12% | -$3.02M | 0.34% | 83 |
|
|
2021
Q3 | $24.4M | Buy |
100,969
+2,564
| +3% | +$646K | 0.39% | 77 |
|
|
2021
Q2 | $23.3M | Sell |
98,405
-21,151
| -18% | -$4.82M | 0.38% | 78 |
|
|
2021
Q1 | $26.2M | Buy |
119,556
+6,207
| +5% | +$1.25M | 0.47% | 70 |
|
|
2020
Q4 | $19.8M | Buy |
113,349
+33,253
| +42% | +$5.74M | 0.37% | 81 |
|
|
2020
Q3 | $13M | Buy |
80,096
+8,092
| +11% | +$1.28M | 0.26% | 100 |
|
|
2020
Q2 | $10.3M | Buy |
72,004
+17,984
| +33% | +$2.49M | 0.23% | 107 |
|
|
2020
Q1 | $5.87M | Sell |
54,020
-1,676
| -3% | -$241K | 0.14% | 122 |
|
|
2019
Q4 | $8.1M | Sell |
55,696
-359
| -0.6% | -$51.8K | 0.15% | 121 |
|
|
2019
Q3 | $8.09M | Buy |
56,055
+472
| +0.8% | +$68.9K | 0.16% | 117 |
|
|
2019
Q2 | $8.26M | Buy |
55,583
+72
| +0.1% | +$10K | 0.17% | 114 |
|
|
2019
Q1 | $7.3M | Buy |
55,511
+1,817
| +3% | +$224K | 0.16% | 119 |
|
|
2018
Q4 | $5.83M | Sell |
53,694
-2,652
| -5% | -$355K | 0.14% | 121 |
|
|
2018
Q3 | $8.41M | Buy |
56,346
+621
| +1% | +$94.5K | 0.18% | 111 |
|
|
2018
Q2 | $8.6M | Buy |
55,725
+19,532
| +54% | +$2.95M | 0.19% | 110 |
|
|
2018
Q1 | $5.03M | Buy |
36,193
+138
| +0.4% | +$20.3K | 0.11% | 148 |
|
|
2017
Q4 | $4.94M | Sell |
36,055
-17,076
| -32% | -$2.26M | 0.11% | 146 |
|
|
2017
Q3 | $6.89M | Sell |
53,131
-1,044
| -2% | -$139K | 0.16% | 125 |
|
|
2017
Q2 | $7.17M | Sell |
54,175
-1,505
| -3% | -$184K | 0.18% | 116 |
|
|
2017
Q1 | $6.86M | Sell |
55,680
-3,777
| -6% | -$447K | 0.17% | 121 |
|
|
2016
Q4 | $6.56M | Sell |
59,457
-107,500
| -64% | -$11.9M | 0.19% | 112 |
|
|
2016
Q3 | $19.7M | Buy |
166,957
+2,387
| +1% | +$281K | 0.56% | 53 |
|
|
2016
Q2 | $18.4M | Sell |
164,570
-1,285
| -0.8% | -$138K | 0.56% | 52 |
|
|
2016
Q1 | $16.7M | Buy |
165,855
+29,909
| +22% | +$2.87M | 0.53% | 58 |
|
|
2015
Q4 | $14.4M | Buy |
135,946
+3,200
| +2% | +$330K | 0.47% | 64 |
|
|
2015
Q3 | $12.4M | Buy |
132,746
+13,556
| +11% | +$1.4M | 0.43% | 76 |
|
|
2015
Q2 | $12.4M | Buy |
119,190
+18,035
| +18% | +$1.88M | 0.39% | 86 |
|
|
2015
Q1 | $11M | Buy |
101,155
+2,430
| +2% | +$250K | 0.35% | 92 |
|
|
2014
Q4 | $9.15M | Buy |
+98,725
| New | +$8.72M | 0.3% | 104 |
|
Other funds holding LH
VCM
VPM
Zacks Investment Management's LH Position: Q1 2026 in Review
Zacks Investment Management reduced its Labcorp (LH) stake by 1.7% in Q1 2026, selling an estimated $397K and leaving 84,157 shares worth $22.5M. The position accounts for 0.18% of the portfolio, ranked #122.
Zacks Investment Management first reported a position in LH in Q4 2014 and has held it in 46 quarters since. The position peaked at $26.2M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Zacks Investment Management held 84,157 shares of Labcorp worth $22.5M as of Q1 2026.
- Zacks Investment Management sold 1,466 Labcorp shares in Q1 2026, an estimated $397K.
- Labcorp made up 0.18% of Zacks Investment Management's portfolio in Q1 2026, its #122 holding.
- Zacks Investment Management first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
- Zacks Investment Management's Labcorp position peaked at $26.2M in Q1 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.